NewsRoom Articles - Page 1345 of 1409

FridayDec 23, 2016 9:17 am

Biotricity, Inc. (BTCY) – A Modern Technology Company for Medical and Consumer Markets

Modern technological advancements are permeating all facets of society and industry and encouraging remote interactions from anywhere and at anytime. In the realm of education, we have seen a rise in the offering of massive open online courses (MOOCs) aimed at unlimited student participation and open access via the web. In the financial services arena, we have seen the rapid growth of technology-driven companies enabling mobile payments and value-added transactional services via e-commerce sites and point-of-sale solutions. It was only a matter of time before we began looking more closely at how the latest developments in technology are influencing the…

ThursdayDec 22, 2016 9:11 am

CytoDyn Inc. (CYDY) Announces Engagement of NetworkNewsWire for Corporate Communications Solutions

CytoDyn Inc. (OTCQB: CYDY), a biotechnology company focused on the development of new antibody therapies for combating human immunodeficiency virus (HIV) infection and other diseases, announced this morning that it has engaged the expertise of NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company that delivers a new generation of social communication solutions, news aggregation and syndication, and enhanced news release services. NNW's strategies help public and private organizations find their voice and build market visibility via social media and a rapidly expanding distribution network of well over 5,000 key syndication outlets. "Maintaining strong communication with CytoDyn shareholders is highly…

WednesdayDec 21, 2016 10:51 am

Net Element, Inc. (NASDAQ: NETE) CEO Joins E2Exchange Advisory Board Following Entry into Newly-Announced Strategic Partnership

Before the opening bell, Net Element, Inc. (NASDAQ: NETE) announced its entry into a strategic partnership with E2Exchange Ltd. (“E2E”) through which the company will provide access to its global multi-channel payment services offering to E2E members. Additionally, Oleg Firer, chief executive officer of Net Element, will serve as a member of E2E’s advisory board moving forward. “We are honored to partner with the growing E2E network,” Firer stated in this morning’s news release. “We look forward to helping E2E members address their global commerce needs, and I am excited to join the E2E advisory board and help companies evaluate…

WednesdayDec 21, 2016 9:14 am

OurPet’s Company (OPCO), Growing 50% Faster than the Industry Rate, Is a Bargain Buy

In the world of value investing, not all that is gold glitters… like Ohio-based OurPet’s Company, for example. OurPet’s Company (OTCQX: OPCO) is a leading proprietary pet supply company that designs, produces, and markets a broad line of innovative, high-quality accessory and consumable pet products under the OurPets® and Pet Zone® brands in the U.S. and international markets. Its yearly revenues have been rising at a steady clip since its inception over 20 years ago and so, too, have its profits. Yet OPCO’s valuation is way below what you might expect. Could this be a case of investors eschewing value…

TuesdayDec 20, 2016 2:15 pm

Net Element (NASDAQ: NETE) Capitalizing on Projected $410.5 Billion Mobile Retail Payment Industry with Value Added Services

Mobile payments have been increasingly adopted since the launch of this new technology back in 2015. By the end of 2016, mobile payments are expected to reach up to $180 billion, and, according to a report entitled ‘Mobile Payments Convergence: Opportunities at the Intersection of In-person, Online and P2P Payments’ (http://nnw.fm/obqQ9), the number of people using mobile wallets in the last 30 days has grown from 12% to nearly one in four people in 2016, approximately 40 million people in the U.S. Experts expect this type of payment to reach a huge $410.5 billion by the end of 2020. So…

TuesdayDec 20, 2016 9:17 am

CytoDyn Inc. (CYDY) Targets HIV as its Lead Product, PRO 140, Enters Phase 3 Clinical Development

CytoDyn Inc. (OTCQB: CYDY) is entering a Phase 3 clinical trial with its leading product candidate, PRO 140, and the Washington-based biotech is showing a lot of progress nearing major milestones. PRO 140 is a viral-entry inhibitor, a new class of HIV/AIDS therapies that work by blocking the entry of the human immunodeficiency virus (HIV) to healthy cells. PRO 140 is presently at the Phase 3 clinical trial stage. For the millions worldwide with HIV/AIDS, PRO 140 could offer the promise of a more robust bodyguard from further viral insult with potentially fewer side effects and hardly any toxicity. HIV,…

MondayDec 19, 2016 1:48 pm

Moxian, Inc. (NASDAQ: MOXC) Capitalizing on its Knowledge of Social Media and O2O Market Demographics in China

Moxian, Inc. (NASDAQ: MOXC), a China-based company in the business of providing social media-based marketing and promotion platforms to merchants to help them grow their business, continues to show a thorough understanding of China’s online-to-offline (O2O) and social media market demographics. Although it is hard to establish where China’s O2O market stands, O2O in China covers all kinds of services that are offered by brick-and-mortar establishments. Unlike in the U.S. or Europe, where O2O is often considered to be items purchased online and picked up at a store, in China O2O includes a range of categories. O2O in China takes…

MondayDec 19, 2016 11:58 am

CytoDyn Inc. (CYDY) is “One to Watch”

CytoDyn Inc. (OTCQB: CYDY) is a Vancouver, Washington-based biotechnology company engaged in the clinical development and potential commercialization of humanized monoclonal antibodies for the treatment and prevention of Human Immunodeficiency Virus (HIV) infection. Monoclonal antibodies – soluble proteins produced by the body in response to infections from bacteria, viruses and other pathogens – have become one of the fastest expanding opportunities in the biotech/pharma sector. CytoDyn’s lead drug candidate is PRO 140, one of the leading monoclonal antibodies under development for HIV infection. PRO 140 belongs to a new class of HIV/AIDS therapeutics intended to protect healthy cells from viral…

MondayDec 19, 2016 9:17 am

Rennova Health, Inc. (NASDAQ: RNVA) Creating the Next Generation of Health Care

Rennova Health, Inc. (NASDAQ: RNVA, RNVAX), a vertically integrated public holding company serving the health care sector, focuses on offering comprehensive single-source solutions to health care providers ranging from diagnostic laboratory testing to technology solutions, revenue cycle management and financial and billing services. With a declared goal of creating efficient, innovative and empowering solutions, the company is dedicated to putting the needs of health care providers and their patients at the center of everything it does. The company’s single-source solutions are designed to help health care providers increase operational efficiency and obtain added value, with the purpose of ultimately supporting…

FridayDec 16, 2016 3:27 pm

Singlepoint, Inc. (SING) CEO Comments on Company’s Above-Average Volume in Interview on MoneyTV with Donald Baillargeon

Before the opening bell, Singlepoint, Inc. (OTC: SING) was announced as a featured company on this week’s episode of MoneyTV with Donald Baillargeon. MoneyTV is an internationally syndicated television program about “money and what makes it happen.” The show includes informative interviews with company CEOs, offering prospective investors insight into their operations and outlooks for the future. To view this week’s program, visit www.MoneyTV.net In the interview, Greg Lambrecht, chief executive officer of Singlepoint, commented on the recent movement of the company’s stock, which has recorded above-average volume throughout much of the past two months. On November 4, in particular,…

Financial news and publishing for public and private companies

Contact us: 512.354.7000